Programme

Download Programme Book

 

Programme at a glance:

The Eurotox 2012 scientific programme spans the variety of interests for academia, industry and regulatory agencies from around the world and covers the significant developments and achievements in science and in regulation.

 

Keynote lectures:

Marie Vahter: Revealing effects of early-life toxic metals exposure - a matter of toxicology, nutrition and epidemiology

Martin Philbert: The new toxicology of sophisticated materials: Nanotoxicology and Beyond

 

High-lighted lectures:

Richard Judson: US EPA – ToxCast and the Tox21 program: perspectives

Susan Jobling: An update of the report “Global Assessment of the State-of-the-Science of Endocrine Disruptors (tentative title)

 

EUROTOX-SOT debate:

Comparative Hazards: Chemicals in the environment Are the Largest Risk to Human Health, David Bell vs Stephen Safe

 

Symposia

  • Chemical exposure-related inflammation and cancer
  • Innovative testing strategies to identify chemical respiratory sensitizers: present and future
  • Neurotoxicology of metals: mechanisms and clinical effects
  • Mechanisms of cell death and survival
  • Mixture toxicity: Current approaches and future strategies
  • From mechanisms of toxicity to biomarkers: addressing current and future needs in drug safety assessment
  • Role of immunosurveillance in chemical carcinogenesis
  • Large populations at risk? News on adverse health effects of low dose exposure to toxic metals
  • From Nanotoxicological Research to Safe Management of nanomaterials
  • Unravelling the natural functions of the aryl hydrocarbon receptor and its proposed endogenous ligands
  • Read-across in risk assessment; problems or possibilities?
  • Pollution from drug manufacturing – assessing and managing risks in different regions of the world
  • New mechanistically based models for evaluation of drug induced liver injury: the IMI Predictive DILI project
  • Clinical toxicology: Are new insights into epidemiology and mechanisms of toxicity changing our approach to important poisonings?
  • Pharmaceuticals in the environment: occurrence, effects on wildlife, and how to reduce the levels
  • Toxicological significance of pharmacogenomics in cancer treatment
  • Dose-response relationship and receptor-mediated toxicology
  • Stem cells in drug discovery and development

 

Work-shops

  • New target organ toxicities of environmental contaminants
  • Toxic exposures in the workplace and the environment: the contribution of biomonitoring to risk assessment
  • The use of mechanistic data in chemical risk assessment
  • New tools in genetics and their application in toxicology
  • Cellular tight junctions – a target for nephrotoxins
  • New in vitro methods for assessment of developmental toxicity endpoints